By expenditures
| Name | Title | Type |
|---|---|---|
| Melissa Morgese | Assistant Superintendent for Business | Auditee |
| Tim Keeley | Assistant Superintendent | Auditee |
| Chuck Gusswein | Assurance Manager | Auditee |
| Don Shaw | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 362740 | 2024 | 2025-07-22 | Lauterbach & Amen LLP | $5.63M |
| 303362 | 2023 | 2024-04-12 | Wipfli LLP | $10.99M |
| 46419 | 2022 | 2023-04-05 | Wipfli LLP | $7.59M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 362740 | 2024 | 2025-07-22 | 1148181 | 2024-006 | Significant Deficiency | - | A |
| 362740 | 2024 | 2025-07-22 | 1148180 | 2024-005 | Significant Deficiency | - | I |
| 362740 | 2024 | 2025-07-22 | 1148179 | 2024-004 | Significant Deficiency | - | N |
| 362740 | 2024 | 2025-07-22 | 1148178 | 2024-003 | Significant Deficiency | Yes | Activities Allowed/Unallowed |
| 362740 | 2024 | 2025-07-22 | 1148177 | 2024-002 | Significant Deficiency | - | Activities Allowed/Unallowed |
| 362740 | 2024 | 2025-07-22 | 1148176 | 2024-001 | Material Weakness | - | Activities Allowed/Unallowed |
| 362740 | 2024 | 2025-07-22 | 571739 | 2024-006 | Significant Deficiency | - | A |
| 362740 | 2024 | 2025-07-22 | 571738 | 2024-005 | Significant Deficiency | - | I |
| 362740 | 2024 | 2025-07-22 | 571737 | 2024-004 | Significant Deficiency | - | N |
| 362740 | 2024 | 2025-07-22 | 571736 | 2024-003 | Significant Deficiency | Yes | Activities Allowed/Unallowed |
| 362740 | 2024 | 2025-07-22 | 571735 | 2024-002 | Significant Deficiency | - | Activities Allowed/Unallowed |
| 362740 | 2024 | 2025-07-22 | 571734 | 2024-001 | Material Weakness | - | Activities Allowed/Unallowed |
| 303362 | 2023 | 2024-04-12 | 969505 | 2023-001 | Significant Deficiency | - | L |
| 303362 | 2023 | 2024-04-12 | 969504 | 2023-001 | Significant Deficiency | - | L |
| 303362 | 2023 | 2024-04-12 | 969503 | 2023-001 | Significant Deficiency | - | L |
| 303362 | 2023 | 2024-04-12 | 969502 | 2023-001 | Significant Deficiency | - | L |
| 303362 | 2023 | 2024-04-12 | 393063 | 2023-001 | Significant Deficiency | - | L |
| 303362 | 2023 | 2024-04-12 | 393062 | 2023-001 | Significant Deficiency | - | L |
| 303362 | 2023 | 2024-04-12 | 393061 | 2023-001 | Significant Deficiency | - | L |
| 303362 | 2023 | 2024-04-12 | 393060 | 2023-001 | Significant Deficiency | - | L |